Assenagon Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $841K | Sell |
12,890
-101,728
| -89% | -$6.64M | ﹤0.01% | 922 |
|
|
2025
Q1 | $7.67M | Sell |
114,618
-196,999
| -63% | -$13.2M | 0.01% | 447 |
|
|
2024
Q4 | $17.2M | Buy |
311,617
+125,438
| +67% | +$6.93M | 0.03% | 360 |
|
|
2024
Q3 | $11.1M | Buy |
186,179
+111,613
| +150% | +$6.66M | 0.02% | 487 |
|
|
2024
Q2 | $4.75M | Sell |
74,566
-9,378
| -11% | -$597K | 0.01% | 627 |
|
|
2024
Q1 | $5.8M | Buy |
83,944
+46,008
| +121% | +$3.18M | 0.01% | 548 |
|
|
2023
Q4 | $2.09M | Sell |
37,936
-61,825
| -62% | -$3.41M | 0.01% | 878 |
|
|
2023
Q3 | $5.79M | Buy |
+99,761
| New | +$5.79M | 0.02% | 516 |
|
|
2021
Q4 | – | Sell |
-33,058
| Closed | -$1.09M | – | 1373 |
|
|
2021
Q3 | $1.09M | Sell |
33,058
-11,559
| -26% | -$379K | ﹤0.01% | 844 |
|
|
2021
Q2 | $1.56M | Sell |
44,617
-18,778
| -30% | -$658K | 0.01% | 738 |
|
|
2021
Q1 | $2.29M | Buy |
63,395
+10,332
| +19% | +$373K | 0.01% | 654 |
|
|
2020
Q4 | $1.54M | Sell |
53,063
-15,194
| -22% | -$441K | 0.01% | 554 |
|
|
2020
Q3 | $1.93M | Sell |
68,257
-74,501
| -52% | -$2.1M | 0.01% | 568 |
|
|
2020
Q2 | $4.62M | Buy |
+142,758
| New | +$4.62M | 0.03% | 321 |
|